PortViewPortView
Medicus Pharma logo

Medicus Pharma (MDCX) Stock Analysis

NASDAQHealthcareBiotechnology

$0.25+1.35%
1-year price historyRange $0.25 – $2.80
52-week range$0.25
$0.24$3.05

What Medicus Pharma does

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Key metrics

Market cap
$5.61M
P/E (TTM)
-0.13
EPS (TTM)
$-1.99
Beta
-0.61
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.34
200-day avg
$0.81
52-week high
$3.05
52-week low
$0.24
CEO
Raza Bokhari

ETFs linked to MDCX

Broad-market and Healthcare sector ETFs an investor holding Medicus Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MDCX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MDCX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Medicus Pharma?
Medicus Pharma trades under the ticker MDCX on NASDAQ.
Which exchange is MDCX listed on?
MDCX is listed on NASDAQ.
What sector does Medicus Pharma operate in?
Medicus Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MDCX in a portfolio?
PortView shows MDCX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.